Molinalogo

Measure / Data Element

2019

2020

2020 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

NA

NA

67.47%

Adult BMI Assessment (ABA)

92.46%

95.13%

93.67%

Annual Dental Visits (ADV)

NB

NB

64.11%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

NA

NA

40.95%

Appropriate Testing for Pharyngitis (CWP)

73.76%

76.13%

86.51%

Appropriate Treatment for Upper Respiratory Infection (URI)

94.43%

92.08%

94.88%

Asthma Medication Ratio (AMR) Total

67.99%

65.48%

68.52%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

39.22%

61.51%

41.07%

Breast Cancer Screening (BCS)

40.36%

40.00%

63.98%

Cervical Cancer Screening (CCS)

53.28%

54.99%

66.49%

Childhood Immunization Status (CIS) Combination #10

36.98%

35.77%

42.02%

Chlamydia Screening in Women (CHL) Total

39.95%

41.14%

66.24%

Comprehensive Diabetes Care (CDC) BP Control < 140/90

67.64%

75.67%

71.44%

Comprehensive Diabetes Care (CDC) HbA1c Control < 8.0%

47.69%

54.26%

55.96%

Comprehensive Diabetes Care (CDC) Eye Exam

52.31%

52.07%

64.72%

Controlling High Blood Pressure (CBP)

55.47%

60.58%

66.91%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

NA

NA

84.27%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

NB

NB

16.93%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

NB

NB

49.65%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

NB

NB

42.69%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

NA

NA

62.69%

Immunizations for Adolescents (IMA) Combination #2

27.74%

27.49%

40.39%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

NB

NB

18.12%

Medication Management for People with Asthma (MMA) Medication Compliance 75% Total

35.80%

36.27%

42.77%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Total

NA

NA

40.90%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

68.18%

65.67%

75.38%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

81.82%

85.07%

87.93%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

62.29%

91.48%

87.59%

Prenatal and Postpartum Care (PPC) Postpartum Care

52.80%

74.70%

69.83%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

75.47%

72.55%

81.24%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

45.00%

48.65%

69.97%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

59.44%

56.82%

67.19%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

58.78%

68.00%

66.42%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

NB

NB

66.58%

Use of Imaging Studies for Low Back Pain (LBP)

66.89%

73.21%

76.02%

Use of Opioids at High Dosage (HDO)

8.16%

12.54%

≤ 2.27%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

3.80%

2.47%

≤ 2.14%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

62.77%

79.32%

85.16%